An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
NCT00652080
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Squamous Cell Carcinoma
Interventions
DRUG:
API 31510
Sponsor
BPGbio